Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
t-cell symbols : Sny save search
BioNTech Presents Positive Phase 1/2 Data Update for CAR-T Cell Therapy Candidate BNT211 in Advanced Solid Tumors at ESMO Congress 2023
Published: 2023-10-23 (Crawled : 15:30) - globenewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 0.73%
H: 0.0%
C: -0.48%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -0.69%
H: 0.0%
C: 0.0%
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: -2.24%
H: 7.12%
C: 4.11%
bnt211 candidate congress tumors positive update cell car-t therapy
Crossbow Therapeutics Launches with $80 Million in Series A Financing to Advance a Novel Class of Antibody Therapies That Mimic T-Cell Receptors to Treat Cancer
Published: 2023-07-11 (Crawled : 13:00) - biospace.com/
LLY | $727.48 -2.48% 2M
|
Health Technology
|
| O: -0.7%
H: 0.12%
C: -2.36%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
antibody t-cell cancer treat therapeutics
Innovent and IASO Bio Updated Efficacy and Safety Clinical Data of Equecabtagene Autoleucel (BCMA CAR-T Cell Therapy) for Multiple Myeloma at the 2023 ASCO Annual Meeting
Published: 2023-06-06 (Crawled : 00:00) - prnewswire.com
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: 0.94%
H: 0.27%
C: 0.02%
INCY | $52.07 -1.42% 800K
|
Health Technology
|
| O: 0.45%
H: 0.14%
C: -1.5%
asco cell meeting car-t
Frazier Life Sciences Adds Highly Experienced T Cell Immunologist to Team
Published: 2023-02-01 (Crawled : 14:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 0.72%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -0.51%
H: 0.0%
C: 0.0%
sciences life
IGM Biosciences Presents Data from T cell Engager Portfolio for Hematologic Malignancies at 2022 American Society of Hematology Annual Meeting
Published: 2022-12-11 (Crawled : 16:20) - globenewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
| Email alert
Add to watchlist
IGMS | $7.25 -2.16% 110K
|
Health Technology
| Email alert
Add to watchlist
meeting
Pfizer and BioNTech Advance Next-Generation COVID-19 Vaccine Strategy with Study Start of Candidate Aimed at Enhancing Breadth of T cell Responses and Duration of Protection
Published: 2022-11-16 (Crawled : 00:00) - globenewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -1.22%
H: 0.0%
C: 0.0%
PFE A | $25.91 2.05% 22M
|
Health Technology
|
| O: -0.52%
H: 1.45%
C: 1.11%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -2.28%
H: 0.0%
C: 0.0%
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: -1.45%
H: 2.36%
C: 2.31%
covid-19 candidate vaccine study
T-cell lymphoma Market 2026, Growing Geriatric Population to Boost Growth - Technavio
Published: 2022-09-26 (Crawled : 06:00) - prnewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 5.77%
H: 0.0%
C: -2.27%
AZNCF | $138.24 800
|
Health Technology
|
| O: -1.15%
H: 0.0%
C: -2.43%
NVS | $93.81 1.34% 1.2M
|
Health Technology
|
| O: -2.04%
H: 0.82%
C: 0.2%
BAX | $39.545 -0.27% 690K
|
Health Technology
|
| O: -0.45%
H: 0.6%
C: -0.45%
ABBV | News | $166.43 1.08% 2M
|
Health Technology
|
| O: -0.69%
H: 0.51%
C: -0.61%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -2.29%
H: 0.35%
C: -0.67%
BIIB | $192.68 1.13% 590K
|
Health Technology
|
| O: -0.17%
H: 1.2%
C: -0.86%
AUTL | $4.635 -3.44% 740K
|
Health Technology
|
| O: 2.94%
H: 1.43%
C: -0.48%
AZN | $68.3 -0.09% 2M
|
Health Technology
|
| O: -1.52%
H: 0.48%
C: -1.36%
growing t-cell growth market
Long term study confirms efficacy of ISA Pharmaceuticals' T-cell activating immunotherapy in combination with checkpoint inhibitor
Published: 2022-03-01 (Crawled : 09:00) - prnewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -3.33%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -1.3%
H: 0.0%
C: 0.0%
als long term cel immunotherapy therapy t-cell
BioNTech and Medigene Announce Global Collaboration to Advance T Cell Receptor Immunotherapies Against Cancer
Published: 2022-02-21 (Crawled : 19:00) - globenewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 1.59%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -1.26%
H: 0.81%
C: 0.46%
BNTX | $86.81 0.74% 230K
|
Health Technology
|
| O: -4.75%
H: 3.0%
C: 0.27%
cel collaboration cancer t-cell immunotherapy
Global Cell & Gene Therapy Market Research Report 2022: Expanding Application for Cell & Gene Therapies & Growing Demand for CAR T- Cell Therapies
Published: 2022-02-01 (Crawled : 21:00) - prnewswire.com
BMY | $48.89 1.22% 5.1M
|
Health Technology
|
| O: -0.53%
H: 0.21%
C: -0.07%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: 0.95%
H: 0.0%
C: 0.0%
ema application gene therapy research cel gene therapies report therapy growing t-cell
Tonix Pharmaceuticals Initiates Enrollment in Clinical Trial of TNX-2100, a Diagnostic Skin Test to Measure Functional T Cell Immunity to SARS-CoV-2
Published: 2022-01-11 (Crawled : 13:30) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -3.41%
H: 5.99%
C: 1.1%
TNXP | $0.1592 1.4% 910K
|
Health Technology
|
| O: 0.75%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: 1.58%
H: 0.0%
C: 0.0%
sars-cov-2 enroll t-cell diagnostic
Allogeneic CAR-T PBCAR0191 with Intensified Lymphodepletion is Highly Active in Subjects with Relapsed/Refractory B-Cell Malignancies
Published: 2022-01-07 (Crawled : 19:00) - precisionbiosciences.com
SNYNF | News | $92.7 600K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
| Email alert
Add to watchlist
DTIL | $9.985 -6.86% 93K
|
Health Technology
| Email alert
Add to watchlist
pbcar0191 car-t cel t-cell
Tonix Pharmaceuticals Announces IND Clearance for Skin Test (TNX-2100) to Measure SARS-CoV-2 Exposure and T Cell Immunity
Published: 2021-12-14 (Crawled : 12:30) - globenewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -3.62%
H: 0.0%
C: -0.56%
TNXP | $0.1592 1.4% 910K
|
Health Technology
|
| O: 5.33%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -0.51%
H: 0.0%
C: 0.0%
tnx-2100 als clearance skin cel sars-cov-2 test t-cell
Global Immunotherapy Drugs Markets 2021-2026 - Launch of NG Immunotherapies / COVID-19 as Growth Catalyst / Approval of Novel Immunotherapy Drugs / Surge in Adoption of Car T-Cell Therapies
Published: 2021-10-28 (Crawled : 18:00) - prnewswire.com
LLY | $727.48 -2.48% 2M
|
Health Technology
|
| O: -0.0%
H: 2.63%
C: 1.28%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: 0.83%
H: 1.2%
C: 0.32%
covid immunotherapy therapy drug growth approval t-cell car-t
Egle Therapeutics Raises 40 Million € Series a to Develop First-In-Class T-regulatory Cells Therapies Based On Treg-starvers
Published: 2021-10-22 (Crawled : 11:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: -0.41%
TAK | News | $13.19 0.23% 740K
|
Health Technology
|
| O: 0.07%
H: 0.5%
C: 0.29%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: 0.0%
therapy
Blackstone Life Sciences, Cellex Cell Professionals, and Intellia Therapeutics Launch New CAR T-Cell Company
Published: 2021-06-22 (Crawled : 12:00) - biospace.com/
BX | $118.86 -1.21% 2.3M
|
Finance
|
| O: 0.0%
H: 1.06%
C: 0.1%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -0.57%
H: 0.25%
C: -0.04%
NTLA | $20.99 -1.55% 560K
|
Health Technology
|
| O: 2.25%
H: 0.49%
C: -2.58%
life science t-cell car-t
Gainers vs Losers
| 71% | 29% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.0503 39.72% 320M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
ZCMD | $1.905 31.38% 30M
|
Commercial Services
NVFY | $2.71 28.44% 31M
|
Consumer Durables
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
TPET | $0.4121 25.68% 45M
|
n/a
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.